Posts for Ticker ‘DGX’

Top Analyst Upgrades (CBS, LH, LXK, MS, ODP, PII, DGX, TLAB, WINN)

These are the few top pre-market analyst upgrades and positive research notes from Wall Street firms early this Friday morning with about two hours until the market opens:

CBS (CBS) Raised to Buy at UBS.
Laboratory Corp. (LH) Started as Outperform at RBC.
Lexmark (LXK) Raised to EqualWeight at Barclays.
Morgan Stanley (MS) Raised to Outperform at KBW.
Office Depot (ODP) raised to Overweight at JPMorgan.
Polaris (PII) Raised to Outperform at Baird.
Quest Diagnostics (DGX) Started as Outperform at RBC.
Tellabs (TLAB) Started as Buy at Auriga.
Winn-Dixie (WINN) Raised to Outperform at FBR.

JON C. OGG

Posted on: May 29, 2009 – 6:35 am in Analyst Calls, , , , , , , , ,

THe 52-Week Low Club (DGX, ED, KDE, SIRF, TWPG, FRNT, PNCL)

Quest Diagnostics Inc. (NYSE: DGX). Cost pressure strains on the health care sector hurting this stock. New low of $43.65 compared to a 52-week high of $58.63.

Consolidated Edison Inc. (NYSE: ED). Poor reaction to volatile fuel prices slid this stock to $39.78 from a 52-wek range of $40.10 to $52.90.

4 Kids Entertainment Inc. (NYSE: KDE). The new low keeps getting lower after a quarter losses posted last week and the economy slows. Down 7% to a new low of $9.56. The 52-week range is $10.19 to $19.90.

SiRF Technology Holdings Inc. (NASDAQ: SIRF). Tuesday’s announcement that job cuts will result from lower sales and UBS analyst predictions that Sirf’s competitive edge will continue to decline dropped the company to a new low of $4.71 from a 52-week range of $4.90 to $30.61

Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG). The bank may have upgraded its security software today, but share prices are anything but secure. New low of $6.81 from a previous 52-week range of $6.99 to $20.80

Huge gains in oil and more FAA inspections not helping any airlines, but these were on lows: Frontier Airlines Holdings, Inc. (NASDAQ: FRNT) Down to $2.05 from a previous range of $2.10 to $7.46. Pinnacle Airlines Corp. (NASDAQ: PNCL) New low of $8.94 from range of $9.13 to $20.34/

Douglas A. McIntyre.

Posted on: March 26, 2008 – 3:00 pm in HI/LOW, , , , , , ,

The 52Week Low Club (CBEY)(BRLC)(BX)(DGX)(LTM)(AVR)

Aventine Renewable Energy (NYSE: AVR) Bad earnings and liquidity issues. Down to $6.79 from 52-week high of $20.85.

Life Time Fitness (NYSE: LTM) Bad outlook from 2008. Sells off to $30.40 from 52-week high of $65.09.

Quest Diagnostics (NYSE: DGX) Forecast is below Wall St. numbers. Falls to $46.44 from 52-week high of $58.63.

Blackstone (NYSE: BX) Environment getting worse for private equity. Drops to $15.25 from 52-week high of $38.

Syntax Brillian (NASDAQ: BRLC) Falls on problems with creditors. Down to $.83 from 52-week high of $9.04.

Cbeyond (NASDAQ: CBEY) Investors not happy with quarterly numbers. Sells down to $15.58 from 52-week high of $46.51.

Douglas A. McIntyre

Posted on: February 22, 2008 – 4:00 pm in HI/LOW, , , , , ,

Top 10 Pre-Market Analyst Calls (AOC, AVAV, CMED, CC, DKS, FCX, INTC, MNI, ODP, DGX)

These aren’t the only analyst calls out there today, but these are the TOP 10 research notes that 24/7 Wall St. is looking at:

  • Aon Corp. (AOC) raised to Buy at Goldman Sachs
  • Aerovironment (AVAV) started as Buy at Sun Trust Robinson Humphrey.
  • China Medtech (CMED) started as Outperform at Bear Stearns.
  • Circuit City (CC) cut to Neutral from Overweight at J.P.Morgan….this actually goes down as the most worthless research call of the week (and maybe this month) as they have had an Outperform rating since December 21, 2006 when shares were over $19.00…congratulations!
  • Dick’s Sporting Goods (DKS) raised to Buy at Citigroup.
  • Freeport McMoRan Copper & Gold (FCX) removed from Goldman Sachs Conviction Buy List.
  • Intel (INTC) started as Neutral at Robert W. Baird.
  • McClatchy (MNI) started as Underperform at Bear Stearns.
  • Office Depot (ODP) raised to Neutral at Credit Suisse; downgraded to Peer Perform from Outperform at Bear Stearns.
  • Quest Diagnostics (DGX) started as Sell at Goldman Sachs.

Jon C. Ogg
November 21, 2007

Posted on: November 21, 2007 – 8:11 am in Analyst Calls, , , , , , , , , ,

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag.  GlaxoSmithkline (GSK) saw the lagest increase, but its short interest is not representative of its real size or activity because it is an ADR and less active here compared to U.K. trade volume.  We ranked hese in terms of percentages with the largest increase in short interest first.

STOCK (Ticker)                JUNE07      MAY07     Change
GlaxoSmithkline (GSK)     7.74M         4.15M       +86%
Boston Scientific (BSX)   32.07M       24.06M       +33.3%
Wyeth (WYE)                          3.3M       10.37M       +28.3%
Labcorp (LH)                       4.11M         3.21M       +28%
Bristol-Myers (BMY)          26.95M       23.85M      +13%
Schering-Plough (SGP)   16.79M      15.27M       +9.9%
Medtronic (MDT)                16.11M      15.19M        +6%
Pfizer (PFE)                        54.48M       52.12M       +4.5%
Quest Diagnost. (DGX)    18.00M       17.54M       +2.6%
Merck (MRK)                       22.82M       22.55M       +1.2%
Eli Lilly (LLY)                       13.77M       14.07M        -2.1%
J&J (JNJ)                             15.37M      16.16M        -4.9%
Zimmer Holdings (ZMH)     3.89M         4.13M        -5.8%
St. Jude MEdical (STJ)        6.53M         7.13M         -8.4%
Genentech (DNA)                 6.87M         8.16M        -15.9%
Abbott Labs (ABT)              11.74M       16.39M        -28.3%

Jon C. Ogg
June 24, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 24, 2007 – 12:16 pm in Biotech, Drug companies, Medical, Short Interest, , , , , , , , , , , , , , , ,

Pre-Market Analyst Calls (June 7, 2007)

ASML raised to Outperform at Bernstein.
CENT cut to Neutral at B of A.
COBZ raised to Outperform at KBW.
DCP raised to Outperform at CIBC.
DGX raised to Buy at UBS.
ECL raised to Buy at Jefferies.
FNM raised to Outperform at FBR.
GD raised to Overweight at Lehman.
HC raised to Overweight at JPMorgan.
IFX raised to Mkt Perform at Bernstein.
IO started as Buy at Jefferies.
KBR started as Outperform at Credit Suisse.
MHS raised to Buy at UBS.
MKC raised to Outperform at Bear Stearns.
OPTM started as Sector Perform at CIBC.
OREX started as Overweight at JPMorgan.
PDLI cut to Mkt Perform at Wachovia.
PG cut to Equal Weight at Lehman.
RDWR raised to Outperform at CIBC.
VOLV cut to Underweight at JPMorgan.
VRUS started as Outperform at JMP Securities.

Jon C. Ogg
June 7, 2007

Posted on: June 7, 2007 – 6:41 am in Analyst Calls, , , , , , , , , , , , , , , , , , , , ,

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  Below is the actual posting from April to May:

STOCK (Ticker)                        MAY07    APR07    Change
Pfizer (PFE)                               52.12M    50.28M    3.6%
Merck (MRK)                             22.55M    18.68M    20.6%
Johnson & Johnson (JNJ)    16.16M    14.47M    11.7%
Abbott Labs (ABT)                   16.39M    14.90M    10%
Wyeth (WYE)                            10.37M    9.61M       7.9%
Eli Lilly (LLY)                            14.07M    10.95M    28.5%
Bristol-Myers (BMY)                23.85M    18.75M    27.2%
Schering-Plough (SGP)        15.27M    14.09M      8.3%
Medtronic (MDT)                      15.19M    13.81M     9.9%
Boston Scientific (BSX)          24.06M    21.65M     11.1%
St. Jude MEdical (STJ)             7.13M    5.85M        21.8%
Quest Diagnost. (DGX)          17.54M    16.57M     11.1%

lower short interest…..

GlaxoSmithkline (GSK)            5.15M    4.66M    -11%
Genentech (DNA)                      8.16M    8.76M    -6.8%
Zimmer Holdings (ZMH)          4.13M    5.00M    -17%
Labcorp (LH)                              3.21M    3.34M    -3.9%

Jon C. Ogg
May 22, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: May 22, 2007 – 4:36 pm in Drug companies, Medical, Pharmaceuticals, Short Interest, , , , , , , , , , , , , , , ,